<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2-5174-19
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2022
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        LOTEMAX 0.5% GEL
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        LOTEPREDNOL ETABONATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        0.5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        %
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Ophthalmic use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        eye gel
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        64.10
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Bausch &amp; Lomb, Incorporated" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Bausch & Lomb, Incorporated
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 583]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ALNAGHI COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Bausch & Lomb, Incorporated
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        S01BA14
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Lotemax is an eye gel.<br />Loteprednol etabonate, the active ingredient in Lotemax, is one of a group of medicines called corticosteroids. It acts by reducing inflammation and eases the symptoms. Because it is used in low doses directly where it is needed, its action is only at this place.<br />Lotemax is used for treatment of inflammation and pain following ocular surgery.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not use Lotemax :<br />- if you are allergic to the active substance (loteprednol etabonate) or any of the other ingredients of this medicine (listed in section 6).<br />- if you have been allergic to any other corticosteroid.<br />- if you have eye diseases caused by viruses such as herpes simplex, vaccinia, and varicella.<br />- if you have eye diseases caused by mycobacterium and fungi.<br />Warnings and precautions:<br />Not for injection into the eye.<br />Tell your doctor if you already have glaucoma.<br />Tell your doctor if pain develops, or if redness, itching, or inflammation gets worse. See your doctor if your symptoms do not get better within 2 days. He/she may want to re-evaluate your condition.<br />You should not use Lotemax longer than 10 days without having the pressure in your eye checked by your doctor.<br />Long-term use of Lotemax or other eye products that contain steroids, may result in glaucoma or raised pressure in the eye, which can cause damage to the optic nerve, problems with vision, and cataracts.<br />Long-term use of Lotemax or other eye products that contain steroids, may lower your ability to fight viral, bacterial or fungal infections and may increase your chance of getting an eye infection including herpes simplex.<br />Using steroid eye gel like Lotemax may make viral diseases of the eye worse and last longer.<br />Contact lens usage<br />You should not wear contact lenses when using Lotemax.<br />Other medicines and Lotemax:<br />Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.<br />&bull;<br />Nonclinical studies in rabbits indicate that the ocular disposition of loteprednol etabonate is not substantially altered by administration with other drugs, including tobramycin. However, no in vitro studies have been conducted to assess the potential for pharmacokinetic drug interactions. Specifically, the effect of loteprednol etabonate on the inhibition or induction of cytochrome P450 enzymes has not been investigated.<br />&bull;<br />Since loteprednol etabonate is not detected in plasma following the topical administration of LOTEMAX, it is not expected to affect the pharmacokinetics of systemically administered medicinal products.<br />&bull;<br />However, the low potential of ocular loteprednol etabonate eye gel to increase the intraocular pressure may be adversely affected by systemically administered medicinal products with anticholinergic activity.<br />&bull;<br />In patients receiving concomitant ocular hypotensive therapy, the addition of loteprednol etabonate may increase intraocular pressure and decrease the apparent ocular hypotensive effect of these medicinal products.<br />&bull;<br />Concurrent administration of cycloplegics may increase the risk of raised intraocular pressure.<br />Pregnancy and breast-feeding<br />If you are pregnant or breast-feeding, or you think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.<br />There are no adequate and well controlled studies in pregnant women. The potential risk for humans is unknown, therefore Lotemax should not be used in pregnancy unless clearly necessary.<br />It is not known whether topical ophthalmic administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in human milk. Caution should be exercised when Lotemax administered to a nursing woman.<br />Driving and using machines<br />No studies on the effects on the ability to drive and use machines after instillation have been performed. However, eye drops/gels/ointments can cause your vision to be blurred which may impair your ability to drive or use machinery. Do not drive or use machines until your vision is clear.<br />Lotemax contains benzalkonium chloride: The preservative benzalkonium chloride may cause eye irritation.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.<br />Apply one to two drops into the conjunctival sac of the affected eye four times daily beginning the day after surgery and continuing throughout the first 2 weeks of the post-operative period.<br />Method of administration<br />&bull; For administration into eye.<br />&bull; Invert closed bottle and shake once to fill tip before instilling drops.<br />&bull; If another topical ophthalmic medicinal product is being used, the medicines should be administered at least ten<br />minutes apart. Eye ointments or gels should be administered last.<br />&bull; Do not allow the tip of the dropper to touch your eye or any other surface because this may contaminate the medicine.<br />&bull; The bottle should be closed immediately after use.<br />&bull; Your doctor will tell you how long your treatment with Lotemax will last.<br />&bull; Do not stop treatment without talking with your doctor.<br />If you use more Lotemax than you should<br />Tell your doctor or a pharmacist.<br />If you forget to use Lotemax<br />Do not take a double dose to make up for a forgotten dose. Wait until the next dose and then continue as before.<br />If you stop using Lotemax<br />Always use this medicine exactly as your doctor has told you. Do not stop using Lotemax without speaking to your doctor first.<br />If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.<br />Adverse reactions associated with ophthalmic steroids include elevated intraocular pressure, which may be associated with optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, delayed wound healing and secondary ocular infection from pathogens including herpes simplex, and perforation of the globe where there is thinning of the cornea or sclera.<br />In clinical studies with loteprednol etabonate ophthalmic gel (LE gel), the most common reported ocular adverse drug reactions were: anterior chamber inflammation, eye pain and foreign body sensation.</p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td style="width:197px">Adverse reactions</td><td style="width:104px">LE gel (N=409)</td><td style="width:198px">Placebo (N=404)</td></tr><tr><td style="width:197px">Eye disorders<br />Anterior chamber inflammation<br />Eye pain<br />Photophobia<br />Foreign body sensation in eyes<br />Iritis<br />Conjunctival haemorrhage<br />Lacrimation increased</td><td style="width:104px">3.7%<br />2.0%<br />1.2%<br />2.0%<br />1.0%<br />1.2%<br />1.5%</td><td style="width:198px">5.9%<br />4.5%<br />3.0%<br />2.0%<br />1.2%<br />0.2%<br />0.0%</td></tr></tbody></table><p>Reporting of side effects<br />Healthcare professionals are asked to report any suspected adverse reactions to:<br />&bull; Saudi Arabia<br />The National Pharmacovigilance and Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />o Toll free phone: 8002490000<br />o Reporting hotline: 19999<br />o E-mail : npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc</p><p>&bull; In United Arab Emirates<br />o Tel: 80011111<br />o Email: pv@moh.gov.ae<br />o P.O.box: 1853 Dubai<br />&bull; Other GCC States: Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not store above 25&deg;C.<br />Store in upright position.<br />Not to be used after 28 days from opening date.<br />DO NOT USE IF PROTECTIVE SEAL IS BROKEN</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- The active ingredient is Loteprednol Etabonate. (0.5%) 5 mg/g<br />- The other ingredients are :<br />&bull; Edetate Disodium Dihydrate<br />&bull; Glycerin<br />&bull; Propylene Glycol<br />&bull; Boric Acid<br />&bull; Polycarbophil<br />&bull; Sodium Chloride<br />&bull; Tyloxapol<br />&bull; Sodium Hydroxide to adjust to a pH of between 6 and 7<br />&bull; Benzalkonium Chloride (0.003%)<br />&bull; Water for injection</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Lotemax 0.5% ophthalmic gel is available in the following packaging configurations:
– 5 mg/g in a 10 ml white low density polyethylene (LDPE) bottle with a white LLDPE controlled drop tip, and a pink polypropylene cap
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing Authorisation Holder and Manufacturer<br />Bausch and Lomb Incorporated<br />Tampa, Florida 33637<br />USA</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                03/2019
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>لوتماكس هو جل للعين.</p><p>ينتمي لوتيبريدنول ايتابونات، المادة الفعالة في لوتماكس، الى مجموعة من الأدوية تعرف باسم كورتيكوستيرويدات والتي تعمل على تقليل الإلتهاب وتخفيف حدة الأعراض. ونظرا لأنها تستخدم بجرعات قليلة وبشكل مباشر عند الحاجة، فإن مغعولها يكون مقصورا على مكان الاستخدام فقط.</p><p>يتم وصف دواء لوتماكس لعلاج الالتهاب والألم بعد إجراء عملية جراحية في العين.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>لا تستخدم لوتماكس في الحالات التالية:</p><p>اذا كنت تعاني من حساسية تجاه المادة الفعالة (لوتيبريدنول ايتابونات) أو أي من مكونات الدواء الأخرى (المدرجة في الجزء رقم6).</p><p>إذا كنت تعاني من حساسية تجاه مواد الكورتيكوستيرويدات الأخرى.</p><p>إذا كنت تعاني من أمراض العيون الناتجة عن الإصابة بالفيروسات مثل فيروس الهربس البسيط وفيروس الوقس وفيروس الجديري.</p><p>إذا كنت تعاني من أمراض العيون الناجمة عن البكتريا الفطرية والفطريات.</p><p>التحذيرات الخاصة والاحتياطات اللازمة للاستخدام:</p><p>ليس للحقن في العين.</p><p>أخبر طبيبك إذا كنت تعاني بالفعل من مرض المياه الزرقاء.</p><p>أخبر طبيبك اذا شعرت بازدياد الألم، أو تفاقم الأحمرار أو الحكة أو الالتهاب.</p><p>استشر/استشيري طبيبك إذا لم تتحسن هذه الأعراض في غضون يومين فقد تحتاج/تحتاجين الى اعادة فحص للحالة.</p><p>يجب ألا تقوم باستخدام دواء لوتماكس لأكثر من 10 أيام بدون إجراء فحص لضغط عينيك بواسطة الطبيب.</p><p>قد يؤدي استخدام لوتماكس لفترة طويلة أو أي من قطرات العين الأخرى التي تحتوي على مادة الستيرويدات الى الاصابة بمرض المياه الزرقاء أو ارتفاع ضغط العينين، مما قد يتسبب بتلف العصب البصري ومشكلات في الرؤية ومرض المياه البيضاء.</p><p>قد يؤدي استخدام لوتماكس لفترة طويلة أو أي من علاجات العين الأخرى التي تحتوي على مادة الستيرويدات إلى تقليل قدرتك على مقاومة العدوى الفيروسية، البكتيرية أو الفطرية، كما قد تزداد فرص اصابتك بعدوى العين مثل فيروس الهربس البسيط.</p><p>قد يؤدي استخدام علاجات العين التي تحتوي على مادة الستيرويدات مثل لوتماكس إلى ازدياد سوء الأمراض الفيروسية بالعين وجعلها تستمر لفترة أطول.</p><p>استخدام العدسات اللاصقة</p><p>لا يجب ارتداء العدسات اللاصقة أثناء العلاج بدواء لوتماكس.</p><p>الأدوية الأخرى ولوتماكس</p><p>عليك أن تقوم بإخبار الطبيب أو الصيدلي المختص في حال استخدامك لأي أدوية أخرى في الفترة الحالية أو في فترة سابقة بما في ذلك الأدوية التي تقوم بشرائها بدون وصفة طبية.</p><p>تشير الدراسات غير السريرية في الأرانب إلى أن التخلص من مادة لوتيبريدنول ايتابونات عن طريق العين لا تتغير بشكل كبير عن طريق تناوله مع أدوية أخرى، يما في ذلك التوبراميسين. ومع ذلك، لم تجر أي دراسات في المختبر لتقييم إمكانات تفاعلات حراكية الدواء. بالتحديد، لم يتم التحقيق في تأثير لوتيبريدنول ايتابونات على تثبيط أو تحريض إنزيمات السيتوكروم P450</p><p>بما أن لم يتم تحديد وجود لوتيبريدنول إيتابونات في البلازما عقب الاستخدام الموضعي في العين، فإنه من غير المتوقع أن يكون له تأثير على حركية الدواء للأدوية المعطاه جهازيا.</p><p>ضعف احتمال حدوث زيادة في ضغط العين مع استخدام لوتيبريدنول إيتابونات، قد يتأثر سلبا عند استخدامه مع الأدوية المثبطة للكولين والتي تعطى جهازيا.</p><p>في المرضى الذين يتلقون العلاج لخفض الضغط المصاحب للعيون، فإن اضافة لوتيبريدنول إيتابونات قد تزيد من الضغط داخل العين وتقلل من تأثير انخفاض ضغط العين الناتج لهذه المنتجات الطبية.</p><p>قد يؤدي الاستخدام المتزامن للأدوية المؤثرة على العضلة الهدبية في العين إلى زيادة خطر حدوث إرتفاع ضغط العين.</p><p>الحمل والرضاعة الطبيعية</p><p>إذا كنت من الحوامل أو المرضعات، تعتقدي أنك قد تكوني حاملا، أو تخططي لإنجاب طفل، قومي باستشارة الطبيب المختص أو الصيدلي قبل استخدام هذا الدواء.</p><p>لا تتوفر دراسات كافية للنساء الحوامل. خطر التشوه الجنيني المحتمل للإنسان غير معروف، لذلك لا ينبغي استخدام لوتماكس خلال الحمل إلا إذا كان ذلك ضروريا بشكل واضح.</p><p>لا توجد معلومات إذا كان الاستخدام الموضعي للكورتيكوستيرويدات في العين قد يؤدي الى امتصاص الجسم بشكل كافي لإفراز كميات يمكن اكتشافها في حليب الأم. يجب اتخاذ الحذر عن اعطاء لوتماكس لأن مرضعة.</p><p>القيادة وتشغيل الالات</p><p>لم يتم اجراء أي دراسات حول التأثير على قدرة القيادة واستخدام الالات بعد الاستخدام. ومع ذلك، يمكن أن تسبب القطرات العينية/جل العين/المراهم العينية إلى حدوث عدم وضوح رؤيتك مما قد يضعف قدرتك على القيادة أو استخدام الالات. لا تقوم بقيادة السيارة أو باستخدم الالات حتى تصبح رؤيتك واضحة.</p><p>يحتوي لوتماكس على مادة كلوريد البنزالكونيوم: قد تتسبب المادة الحافظة الموجودة (كلوريد البنزالكونيوم) في حدوث تهيج بالعين.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>قم باستعمال هذا الدواء بناء على وصف الطبيب أو الصيدلي دائما. استشر طبيبك أو الصيدلي اذا كنت غير متأكد.</p><p>ضع نقطة أو نقطتين من لوتماكس في ملتحمة العين المصابة أربع مرات يوميا بداية من اليوم التالي للعملية مع الاستمرار لأول اسبوعين من بعد اجراء العملية الجراحية.</p><p>طريقة الاستخدام</p><p>للاستخدام الموضعي في العين.</p><p>اقلب الزجاجة المغلقة وقم برجها مرة واحدة لتملأ طرفها قبل وضع النقط.</p><p>عند استخدام لوتماكس جل مع دواء موضعي للاستخدام في العين، يجب أن يكون الفارق الزمني 10 دقائق على الأقل. على أن يوضع المرهم أو الجل آخرا.</p><p>يجب ألا تسمح لطرف القطارة بلمس عينيك أو اي سطح آخر لكي لا يتلوث الدواء.</p><p>يجب غلق الزجاجة بمجرد الإنتهاء من الاستخدام.</p><p>سيخبرك الطبيب بمدة العلاج.</p><p>لا يجب أن توقف العلاج من تلقاء نفسك، دون استشارة الطبيب.</p><p>اذا استخدمت الدواء بجرعة أكبر من الموصوفة</p><p>اسأل الطبيب أو الصيدلي.</p><p>في حال نسيان استخدام الجرعة المخصصة من لوتماكس</p><p>لا تقم بوضع جرعة مضاعفة لتعويض الجرعة المنسية.</p><p>قم بالانتظار&nbsp; حتى يحين موعد استخدام الجرعة التالية، وبعدها قم باستخدام الجرعات في موعدها المحدد.</p><p>إذا توقفت عن استخدام لوتماكس</p><p>عليك أن تقوم باستعمال هذا الدواء بناء على وصف الطبيب دائما. لا تقوم بالتوقف عن استخدام العلاج من تلقاء نفسك ولا تفعل ذلك دون التحدث مع طبيبك أولا.</p><p>في حال كانت لديك أي اسئلة أخرى حول طريقة استخدام هذا الدواء، قم بطرحها على الطبيب أو الصيدلي.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>كما هو الحال بالنسبة لجميع الأدوية الأخرى، فقد يتسبب هذا الدواء في ظهور أعراض جانبية، إلا أن هذه الأعراض قد لا تحدث لجميع المرضى.</p><p>الآثار الجانبية المصاحبة لاستخدام العقاقير التي تحتوي على مادة الستيرويدات تتمثل في: ارتفاع ضغط العين الذي يصاحبه أحيانا تلف بالعصب البصري، تدهور القدرة على الإبصار وضعف الرؤية، حدوث مياه بيضاء بعدسة العين الموجودة خلف محفظة العين، تأخر التئام الجرح مع امكانية حدوث عدوى ثانوية بالعين الناتج عن مسببات الأمراض مثل فيروس الهيربس البسيط، وحدوث ثقب بمقة العين عند وجود ترقق في الصلبة أو القرنية.</p><p>الآثار الجانبية الأكثر شيوعا التي سجلت في الدراسات السريرية: التهاب حجيرة العين الأمامية، آلام العين، والشعور بوجود جسم غريب في العين.</p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td style="width:185px">الاثار غير المرغوب بها</td><td style="width:185px">جل لوتيبريدنول ايتابونات (N=409)</td><td style="width:131px">علاج بديل (N=404)</td></tr><tr><td style="width:185px"><p>اضطرابات العين</p><p>التهاب حجيرة العين الأمامية</p><p>آلام العين</p><p>فوبيا الضوء</p><p>الشعور بوجود جسم غريب في العين</p><p>التهاب القزحية</p><p>نزيف الملتحمة</p><p>زيادة إفراز الدموع</p></td><td style="width:185px"><p>3.7%</p><p>2.0%</p><p>1.2%</p><p>2.0%</p><p>1.0%</p><p>1.2%</p><p>1.5%</p><p>&nbsp;</p></td><td style="width:131px"><p>5.9%</p><p>4.5%</p><p>3.0%</p><p>2.0%</p><p>1.2%</p><p>0.2%</p><p>0.0%</p></td></tr></tbody></table><p>الابلاغ عن ظهور آثار جانبية</p><p>ينبغي على اخصائي الرعاية الصحية أن يقوموا بالإبلاغ عن الآثار الجانبية المشكوك بوجودها.</p><p>المملكة العربية السعودية:</p><p>المركز الوطني للتيقظ والسلامة الدوائية - المملكة العربية السعودية.</p><p>فاكس: +966-11-205-7662</p><p>قم بالاتصال بالمركز على الأرقام التالية: +966112038222؛ تحويلة:</p><p>2340-2334-2354-2353-23536-2317</p><p>الهاتف المجاني: 8002490000</p><p>الخط الساخن للإبلاغ: 19999</p><p>البريد الالكتروني: npc.drug@sfda.gov.sa</p><p>الموقع الالكتروني: www.sfda.gov.sa/npc</p><p>دولة الامارات العربية المتحدة</p><p>هاتف: 80011111</p><p>بريد الكتروني: pv@moh.gov.ae</p><p>صندوق بريد: 1853 دبي</p><p>للاتصال بدول أخرى بمجلس التعاون الخليجي: يرجى الاتصال بالسلطات المختصة.</p><p>&nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ في درجة حرارة لا تزيد عن 25 مئوية.</p><p>يتم تخزين الدواء في وضع قائم.</p><p>يرجى التخلص من القطرات بعد مرور 28 يوما من تاريخ فتح العبوة.</p><p>لا يستخدم ان كان عازل الحماية غير سليم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة: لوتيبريدنول ايتابونات 5ملجم/جم (0.5%).</p><p>المواد الأخرى:</p><p>ايديتات ثنائي الصوديوم ثنائي الهيدرات.</p><p>الجليسرين.</p><p>جلايكول البروبيلين.</p><p>حمض البوريك.</p><p>بولي كربوفيل</p><p>كلوريد الصوديوم</p><p>تيلوكسابول</p><p>هيدروكسيد الصوديوم لضبط درجة الحموضة ما بين 6و7</p><p>كلوريد البنزالكونيوم (0.003%)</p><p>ماء للحقن</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>لوتماكس 0.5% خو جل للعين يأتي بالعبوة الموضحة تاليا:</p><p>5ملجم/جم في زجاجة بيضاء بلاستيكية من البولي اثيلين منخفض الكثافة حجم 10مل وطرفها أبيض من مادة البولي بروبيلين وغطاء وردي اللون.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>الشركة المصنعة ومالكة حق التسويق</p><p>بوش اند لومب انكوربوريتد</p><p>تامبا، فلوريدا 33637</p><p>الولايات المتحدة الامريكية</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            03/2019
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Lotemax 0.5% ophthalmic gel 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The ophthalmic gel contains 0.5% loteprednol etabonate. 
Each gram of the ophthalmic gel contains 5 mg of loteprednol etabonate as a sterile preserved ophthalmic gel. 
Excipient with known effect: benzalkonium chloride (0.003%) 
For the full list of excipients, see section 6.1. 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Ophthalmic gel 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment of post-operative inflammation and pain following ocular surgery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology</p><p>One to two drops into the conjunctival sac of the affected eye four times daily beginning the day after surgery and continuing throughout the first 2 weeks of the post-operative period.&nbsp;</p><p>Method of administration&nbsp;<br />Ocular administration.&nbsp;<br />Invert closed bottle and shake once to fill tip before instilling drops.&nbsp;<br />If another topical ophthalmic medicinal product is being used, the medicines should be administered at least ten minutes apart. Eye ointments or gels should be administered last.&nbsp;</p><p>This product is a sterile preserved ophthalmic gel. It can be used only if imprinted neckband is intact. Patients should be instructed to wash their hands before use and avoid allowing the dropper tip to contact the eye, surrounding structures and any other surface.&nbsp;<br />Patients should also be instructed that ophthalmic medicinal products, if handled improperly, can become contaminated by common bacteria known to cause ocular infections. Serious damage to the eye and subsequent loss of vision may result from using contaminated gels. If pain develops, redness, itching or inflammation becomes aggravated, the patient should be advised to consult a physician. &nbsp;</p><p>As with other ophthalmic preparations containing benzalkonium chloride, patients should be advised not to wear soft contact lenses when using Lotemax. The bottle should be closed immediately after use.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance, to other corticosteroids  or to any of the excipients listed in section 6.1.
As with other ophthalmic corticosteroids, Lotemax is also contraindicated in most viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures. 
untreated purulent acute infections which, similar to other infectious diseases, can be masked and worsened by corticoids, ‘red eye’ with unknown diagnosis and infection caused by amoeba. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not for injection into the eye.&nbsp;<br />Intraocular Pressure (IOP) Increase&nbsp;<br />Prolonged use of corticosteroids may result in ocular hypertension or glaucoma with damage to the optic nerve, defects in visual acuity and fields of vision. Steroids should be used with caution in the presence of glaucoma. If this product is used for 10 days or longer, intraocular pressure should be monitored.&nbsp;</p><p>Cataracts&nbsp;<br />Use of corticosteroids may result in posterior subcapsular cataract formation.&nbsp;</p><p>Delayed Healing&nbsp;<br />The use of steroids after cataract surgery may delay healing and increase the incidence of bleb formation. In those diseases causing thinning of the cornea or sclera, perforations have been known to occur with the use of topical steroids. The initial prescription and renewal of the medication order should be made by a physician only after examination of the patient with the aid of magnification such as slit lamp biomicroscopy and, where appropriate, fluorescein staining.&nbsp;</p><p>Bacterial Infections&nbsp;<br />Prolonged use of corticosteroids may suppress the host response and thus may increase the possibility of secondary ocular infections. In those diseases causing thinning of the cornea or sclera, perforations have been known to occur with the use of topical steroids. In acute purulent conditions of the eye, steroids may mask infection or enhance existing infection.&nbsp;</p><p>Viral Infections&nbsp;<br />Employment of a corticosteroid medication in the treatment of patients with a history of herpes simplex requires great caution. Use of ocular steroids may prolong the course and may exacerbate the severity of many viral infections of the eye (including herpes simplex).&nbsp;</p><p>Fungal Infections&nbsp;<br />Fungal infections of the cornea are particularly prone to develop coincidentally with long-term local steroid application. Fungus invasion must be considered in the differential diagnosis in any persistent corneal ulceration where a steroid has been used or is in use. Fungal cultures should be taken when appropriate.&nbsp;</p><p>Contact Lens Wear&nbsp;<br />Patients should not wear contact lenses during their course of therapy with Lotemax.&nbsp;<br />Lotemax contains benzalkonium chloride which may cause eye irritation and is known to discolour soft contact lenses.&nbsp;<br />Special populations&nbsp;<br />No overall differences in safety and effectiveness have been observed between elderly and younger patients.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Nonclinical studies in rabbits indicate that the ocular disposition of loteprednol etabonate is not substantially altered by administration with other drugs, including tobramycin. However, no in vitro studies have been conducted to assess the potential for pharmacokinetic drug interactions. Specifically, the effect of loteprednol etabonate on the inhibition or induction of cytochrome P450 enzymes has not been investigated.&nbsp;<br />Since loteprednol etabonate is not detected in plasma following the topical administration of LOTEMAX, it is not expected to affect the pharmacokinetics of systemically administered medicinal products.&nbsp;<br />However, the low potential of ocular loteprednol etabonate eye gel to increase the intraocular pressure may be adversely affected by systemically administered medicinal products with anticholinergic activity. In patients receiving concomitant ocular hypotensive therapy, the addition of loteprednol etabonate may increase intraocular pressure and decrease the apparent ocular hypotensive effect of these medicinal products.&nbsp;</p><p>Concurrent administration of cycloplegics may increase the risk of raised intraocular pressure.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy&nbsp;<br />Teratogenic Effects:&nbsp;<br />There are no adequate and well controlled studies in pregnant women. However, studies in animals have &nbsp;shown reproductive toxicity (see section 5.3). The potential risk for humans is unknown, therefore Lotemax should not be used in pregnancy unless clearly necessary. &nbsp;</p><p>Breastfeeding&nbsp;<br />It is not known whether topical ophthalmic administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in human milk. Systemically administered corticosteroids appear in human milk and could suppress growth, interfere with endogenous corticosteroid production, or cause other untoward effects. Caution should be exercised when LE is administered to a &nbsp;nursing woman.&nbsp;<br />Fertility&nbsp;<br />Animal reproductive studies of loteprednol etabonate have revealed no evidence of impairment fertility (see section 5.3).&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effects on the ability to drive and use machines after instillation have been performed.&nbsp;<br />However, as all products administered to eye, it may cause transient blurred vision, which may impair the ability to drive or to use machinery, especially at night or in reduced lighting. The patient should wait until these symptoms have cleared before driving or using machinery.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse reactions associated with ophthalmic steroids include elevated intraocular pressure, which may be associated with optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, delayed wound healing and secondary ocular infection from pathogens including herpes simplex, and perforation of the globe where there is thinning of the cornea or sclera.&nbsp;<br />In clinical studies with loteprednol etabonate ophthalmic gel (LE gel), the most common reported ocular adverse drug reactions were: anterior chamber inflammation, eye pain and foreign body sensation&nbsp;</p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td>Adverse reactions</td><td>LE gel (N=409)</td><td>Placebo (N=404)</td></tr><tr><td><p>Eye disorders</p><p>Anterior chamber inflammation</p><p>Eye pain&nbsp;<br />Photophobia&nbsp;<br />Foreign body sensation in eyes&nbsp;</p><p>Iritis&nbsp;<br />Conjunctival haemorrhage</p><p>Lacrimation increased&nbsp;</p></td><td><p>3.7%</p><p>2.0%</p><p>1.2%</p><p>2.0%</p><p>1.0%</p><p>1.2%</p><p>1.5%</p></td><td><p>5.9%</p><p>4.5%</p><p>3.0%</p><p>2.0%</p><p>1.2%</p><p>0.2%</p><p>0.0%</p></td></tr></tbody></table><p>To report any side effect(s):</p><p>Saudi Arabia:</p><p>-&nbsp;&nbsp; &nbsp;The National Pharmacovigilance and Drug Safety Centre (NPC)<br />&bull;&nbsp;&nbsp; &nbsp;Fax: &nbsp;+966-11-205-7662<br />&bull;&nbsp;&nbsp; &nbsp;Call NPC at +966-11-2038222, Exts: &nbsp;2317-2356-2353-2354-2334-2340.<br />&bull;&nbsp;&nbsp; &nbsp;Toll free phone: 8002490000<br />&bull;&nbsp;&nbsp; &nbsp;Reporting hotline: 19999<br />&bull;&nbsp;&nbsp; &nbsp;E-mail: npc.drug@sfda.gov.sa<br />&bull;&nbsp;&nbsp; &nbsp;Website: &nbsp;www.sfda.gov.sa/npc</p><p>Other GCC States: Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Acute overdosage is unlikely to occur via the ophthalmic route. Particularly with the use of topical gel.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Corticosteroids, ATC code: S01BA14&nbsp;<br />Mechanism of action&nbsp;<br />Corticosteroids inhibit the inflammatory response to a variety of inciting agents and probably delay or slow healing. They inhibit the edema, fibrin deposition, capillary dilation, leukocyte migration, capillary proliferation, fibroblast proliferation, deposition of collagen, and scar formation associated with inflammation. While glucocorticoids are known to bind to and activate the glucocorticoid receptor, the molecular mechanisms involved in glucocorticoid/glucocorticoid receptor-dependent modulation of inflammation are not clearly established. However, corticosteroids are thought to inhibit prostaglandin production through several independent mechanisms.&nbsp;</p><p>Loteprednol etabonate is a new class of corticosteroid with potent antiinflammatory activity designed to be active at the site of action. Its antiinflammatory activity is similar to the most powerful steroid used in ophthalmology but with less intraocular pressure. Receptor binding studies have shown that loteprednol etabonate has a binding affinity to steroid receptors that is 4.3 times greater than dexamethasone and that binds competitively to transcortin, a corticosteroid-binding plasma protein. &nbsp;Loteprednol etabonate is structurally similar to other corticosteroids. However, unlike other corticosteroids loteprednol etabonate is an ester rather than a ketone (position 20). This new class of steroids consists of bioactive molecules whose in-vivo transformation to non-toxic substances can be predicted from their chemistry and knowledge of enzymatic pathways in the body. Cortienic acid is an inactive metabolite of hydrocortisone and analogs of cortienic acid are also devoid of corticosteroid activity. Loteprednol etabonate is an ester derivative of one of these analogs, cortienic acid etabonate.&nbsp;</p><p>Clinical efficacy and safety&nbsp;</p><p>In two randomized, multicenter, double-masked, parallel-group, placebo-controlled studies in 813 adult subjects (409 subjects treated with Lotemax gel and 404 treated with placebo) with, post-operative inflammation, Lotemax was more effective compared to its vehicle as a placebo in resolving anterior chamber inflammation and pain following cataract surgery. Primary endpoints were complete resolution of anterior chamber cells (cell count of 0) and no pain at post-operative day 8. In these studies, Lotemax had a statistically significant higher incidence of subjects with complete clearing of anterior chamber cells (31% vs. 14-16%) and were pain free at post-operative day 8 (73-76% vs. 42-46%).&nbsp;</p><p>The safety and effectiveness of Lotemax were evaluated in a pediatric study of patients from birth to less than 11 years of age (mean age of 3 years) undergoing cataract surgery. Patients were randomized, to receive either Lotemax (54 patients) or prednisolone acetate ophthalmic suspension 1% (53 patients) four times a day for 14 days. At Day 14, the percentages of patients with complete clearing of anterior chamber inflammation were 57% in the Lotemax group and 63% in the prednisolone group.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Loteprednol is lipid soluble and can penetrate into cells. Loteprednol etabonate is synthesized through structural modifications of prednisolone-related compounds so that it will undergo a predictable transformation to an inactive metabolite. Based upon in vivo and in vitro preclinical studies loteprednol etabonate undergoes extensive metabolism to the inactive carboxylic acid metabolites, PJ-91 and PJ-90. Results from the nonclinical evaluation of LE demonstrate that it is rapidly absorbed into ocular tissues with minimal (eg, &lt;1 ng/mL) systemic exposure following topical ocular administration. The systemic exposure to loteprednol etabonate following ocular administration of Lotemax has not been studied in humans.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data reveal no special hazard for humans based on conventional studies of repeated dose and genotoxicity.&nbsp;<br />Carcinogenic potential&nbsp;<br />Long-term animal studies have not been conducted to evaluate the carcinogenic potential of loteprednol etabonate.&nbsp;<br />Genotoxicity&nbsp;<br />Loteprednol etabonate was not genotoxic in vitro in the Ames test, the mouse lymphoma TK assay, or in a chromosome aberration test in human lymphocytes, or in vivo in the single dose mouse micronucleus assay.&nbsp;</p><p>Reproductive toxicity&nbsp;<br />Loteprednol etabonate has been shown to be embryotoxic (delayed ossification) and teratogenic (increased incidence of meningocele, abnormal left common carotid artery, and limb flexures) when administered orally to rabbits during organogenesis at a dose of 3 mg/kg/day (35 times the maximum daily clinical dose), a dose which caused no maternal toxicity. The no-observed-effect-level (NOEL) for these effects was 0.5 mg/kg/day (6 times the maximum daily clinical dose). Oral treatment of rats during organogenesis resulted in teratogenicity (absent innominate artery at &ge;5 mg/kg/day doses, and cleft palate and umbilical hernia at&nbsp;<br />&ge;50 mg/kg/day) and embryotoxicity (increased post-implantation losses at 100 mg/kg/day and decreased fetal body weight and skeletal ossification with &ge;50 mg/kg/day). Treatment of rats with 0.5 mg/kg/day (6 times the maximum clinical dose) during organogenesis did not result in any reproductive toxicity.&nbsp;<br />Loteprednol etabonate was maternally toxic (significantly reduced body weight gain during treatment) when administered to pregnant rats during organogenesis at doses of &ge;5 mg/kg/day.&nbsp;<br />Oral exposure of female rats to 50 mg/kg/day of loteprednol etabonate from the start of the fetal period through the end of lactation, a maternally toxic treatment regimen (significantly decreased body weight gain), gave rise to decreased growth and survival, and retarded development in the offspring during lactation; the NOEL for these effects was 5 mg/kg/day. Loteprednol etabonate had no effect on the duration of gestation or parturition when administered orally to pregnant rats at doses up to 50 mg/kg/day during the fetal period.&nbsp;<br />Fertility&nbsp;<br />Treatment of male and female rats with up to 50 mg/ kg/day and 25 mg/kg/day of loteprednol etabonate, respectively prior to and during mating did not impair fertility in either gender.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Edetate Disodium&nbsp;<br />Dihydrate Glycerin&nbsp;<br />Propylene&nbsp;<br />Glycol Boric&nbsp;<br />Acid&nbsp;<br />Polycarbophil&nbsp;<br />Sodium&nbsp;<br />Chloride&nbsp;<br />Tyloxapol&nbsp;<br />Sodium Hydroxide to adjust to a pH of between 6 and 7&nbsp;<br />Benzalkonium &nbsp;Chloride (0.003%)&nbsp;<br />Water for injection&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Un opened: 2 years 
The in-use shelf-life is 28 days from opening date. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 25 C. Do not Freeze.&nbsp;<br />Store the container in upright position.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Lotemax 0.5% ophthalmic gel is available in the following &nbsp;packaging configurations:</p><p>5 g in a 10 ml white low density polyethylene (LDPE) bottle with a white LLDPE controlled drop tip, and a pink polypropylene cap</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.&nbsp;<br />Use only if imprinted neckband is intact.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Bausch & Lomb Incorporated Tampa 
،Florida 33637 
USA 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                02/2019
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>